| # | Title | Journal | Year | Citations |
|---|
|
| 1 | 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial | Lancet, The | 2016 | 589 |
| 2 | Genomic hallmarks of localized, non-indolent prostate cancer | Nature | 2017 | 485 |
| 3 | Human papillomavirus positive squamous cell carcinoma of the oropharynx | Cancer | 2001 | 425 |
| 4 | Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patients | International Journal of Radiation Oncology Biology Physics | 2006 | 232 |
| 5 | Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial | Lancet Oncology, The | 2017 | 226 |
| 6 | Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry | International Journal of Hyperthermia | 2015 | 178 |
| 7 | A Comparative Analysis of Individual RAS Mutations in Cancer Biology | Frontiers in Oncology | 2019 | 174 |
| 8 | The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants | Oncogene | 2004 | 173 |
| 9 | Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042) | Radiotherapy and Oncology | 2018 | 134 |
| 10 | The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer | International Journal of Cancer | 2009 | 131 |
| 11 | Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network | Lancet Oncology, The | 2006 | 130 |
| 12 | Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates | Acta Oncológica | 2019 | 129 |
| 13 | ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost – GEC-ESTRO Breast Cancer Working Group practical recommendations | Radiotherapy and Oncology | 2018 | 119 |
| 14 | Multi-Modal Glioblastoma Segmentation: Man versus Machine | PLoS ONE | 2014 | 119 |
| 15 | Recommendations from GEC ESTRO Breast Cancer Working Group (I): Target definition and target delineation for accelerated or boost Partial Breast Irradiation using multicatheter interstitial brachytherapy after breast conserving closed cavity surgery | Radiotherapy and Oncology | 2015 | 112 |
| 16 | Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial | Lancet Oncology, The | 2018 | 104 |
| 17 | Breast cancer and human papillomavirus (HPV) infection: No evidence of a viral etiology in a group of Swiss women | Breast | 2007 | 94 |
| 18 | GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance | Radiotherapy and Oncology | 2016 | 94 |
| 19 | Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study | Lancet Oncology, The | 2020 | 90 |
| 20 | Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov | Radiation Oncology | 2017 | 88 |
| 21 | Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network | Neuro-Oncology | 2015 | 85 |
| 22 | Involvement of the hepatocyte growth factor/scatter factor receptor c-met and of Bcl-xL in the resistance of oropharyngeal cancer to ionizing radiation | International Journal of Cancer | 2001 | 83 |
| 23 | Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers | European Radiology | 2013 | 78 |
| 24 | Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer | British Journal of Cancer | 2014 | 75 |
| 25 | Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy | Brachytherapy | 2009 | 73 |
| 26 | Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial | European Urology | 2021 | 72 |
| 27 | PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial | BMC Cancer | 2020 | 68 |
| 28 | The Essential Role of Radiotherapy in the Treatment of Merkel Cell Carcinoma: A Study From the Rare Cancer Network | International Journal of Radiation Oncology Biology Physics | 2011 | 67 |
| 29 | Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma | Cell Death and Disease | 2019 | 65 |
| 30 | Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy | Journal of Translational Medicine | 2018 | 64 |
| 31 | Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx | Oncogene | 2003 | 60 |
| 32 | Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation Therapy | International Journal of Radiation Oncology Biology Physics | 2017 | 60 |
| 33 | Therapy options and long-term results of sinonasal malignancies | Oral Oncology | 2012 | 59 |
| 34 | Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94) | Radiation Oncology | 2015 | 59 |
| 35 | Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes | Radiotherapy and Oncology | 2020 | 59 |
| 36 | CCL20/CCR6 expression profile in pancreatic cancer | Journal of Translational Medicine | 2010 | 56 |
| 37 | MRI of Merkel Cell Carcinoma: Histologic Correlation and Review of the Literature | American Journal of Roentgenology | 2005 | 54 |
| 38 | Prevalence and predictors of fatigue in glioblastoma: a prospective study | Neuro-Oncology | 2015 | 52 |
| 39 | MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaks | International Journal of Cancer | 2012 | 51 |
| 40 | Quantitative Analysis of Extracapsular Extension of Metastatic Lymph Nodes and its Significance in Radiotherapy Planning in Head and Neck Squamous Cell Carcinoma | International Journal of Radiation Oncology Biology Physics | 2010 | 50 |
| 41 | Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation | Radiation Oncology | 2018 | 49 |
| 42 | Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx | International Journal of Radiation Oncology Biology Physics | 2000 | 48 |
| 43 | Tumour control and Quality of Life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy | Radiotherapy and Oncology | 2016 | 48 |
| 44 | Gefitinib in Combination With Irradiation With or Without Cisplatin in Patients With Inoperable Stage III Non–Small Cell Lung Cancer: A Phase I Trial | International Journal of Radiation Oncology Biology Physics | 2011 | 46 |
| 45 | Fully automated brain resection cavity delineation for radiation target volume definition in glioblastoma patients using deep learning | Radiation Oncology | 2020 | 46 |
| 46 | MET targeting: time for a rematch | Oncogene | 2020 | 45 |
| 47 | MET Inhibition Results in DNA Breaks and Synergistically Sensitizes Tumor Cells to DNA-Damaging Agents Potentially by Breaching a Damage-Induced Checkpoint Arrest | Genes and Cancer | 2010 | 44 |
| 48 | Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist | British Journal of Radiology | 2016 | 44 |
| 49 | Synergistic action of image-guided radiotherapy and androgen deprivation therapy | Nature Reviews Urology | 2015 | 43 |
| 50 | Effect of preoperative immunonutrition on complications after salvage surgery in head and neck cancer | Journal of Otolaryngology - Head and Neck Surgery | 2019 | 43 |
